AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Kaiser Aluminum
KALU
$2.61B
| $2M | ﹤0.01% |
25,770
| – | – |
|
1827
Pacira BioSciences
PCRX
$1.04B
| $2M | ﹤0.01% |
61,930
| – | – |
|
|
LQ
1828
DELISTED
La Quinta Holdings Inc.
LQ
| $2M | ﹤0.01% |
140,500
-2,460
| -2% | -$29.2K |
|
1829
Ameris Bancorp
ABCB
$5.85B
| $2M | ﹤0.01% |
45,754
| – | – |
|
1830
Omnicell
OMCL
$1.61B
| $2M | ﹤0.01% |
58,846
| – | – |
|
|
PLKI
1831
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $1.99M | ﹤0.01% |
32,963
| – | – |
|
1832
OSI Systems
OSIS
$3.65B
| $1.99M | ﹤0.01% |
26,181
-4,700
| -15% | -$339K |
|
1833
LPL Financial
LPLA
$28.3B
| $1.99M | ﹤0.01% |
56,583
-1,180
| -2% | -$41.2K |
|
1834
CONMED
CNMD
$1.39B
| $1.99M | ﹤0.01% |
45,067
| – | – |
|
|
IXYS
1835
DELISTED
IXYS Corp
IXYS
| $1.99M | ﹤0.01% |
167,220
-32,470
| -16% | -$369K |
|
|
CKH
1836
DELISTED
Seacor Holdings Inc.
CKH
| $1.99M | ﹤0.01% |
28,849
+414
| +1% | +$24.3K |
|
1837
Sarepta Therapeutics
SRPT
$1.57B
| $1.99M | ﹤0.01% |
72,450
+9,700
| +15% | +$390K |
|
|
ARRY
1838
DELISTED
Array Biopharma Inc
ARRY
| $1.99M | ﹤0.01% |
225,929
+27,600
| +14% | +$203K |
|
1839
Telephone and Data Systems
TDS
$3.82B
| $1.98M | ﹤0.01% |
68,533
+1,786
| +3% | +$48.7K |
|
|
AXON
1840
Axon Enterprise
AXON
$42.5B
| $1.97M | ﹤0.01% |
81,256
| – | – |
|
1841
Timken Company
TKR
$9.56B
| $1.97M | ﹤0.01% |
49,629
-1,060
| -2% | -$39.4K |
|
1842
Protolabs
PRLB
$1.79B
| $1.97M | ﹤0.01% |
38,350
-83
| -0.2% | -$4.35K |
|
1843
John Wiley & Sons Class A
WLY
$2.65B
| $1.97M | ﹤0.01% |
36,101
-640
| -2% | -$34.1K |
|
1844
Herbalife
HLF
$1.29B
| $1.97M | ﹤0.01% |
81,706
-1,448
| -2% | -$39.5K |
|
|
HSNI
1845
DELISTED
HSN, Inc.
HSNI
| $1.96M | ﹤0.01% |
57,031
-20
| -0% | -$747 |
|
|
SKX
1846
DELISTED
Skechers
SKX
| $1.95M | ﹤0.01% |
79,403
-1,283
| -2% | -$29.6K |
|
|
ALR
1847
PUT
DELISTED
Alere Inc
ALR
| $1.95M | ﹤0.01% |
+50,000
| New | +$2.02M |
|
|
MBTF
1848
DELISTED
MBT Financial Corporation
MBTF
| $1.94M | ﹤0.01% |
+171,260
| New | +$1.67M |
|
|
MFA
1849
MFA Financial
MFA
$926M
| $1.93M | ﹤0.01% |
63,233
-1,375
| -2% | -$41.3K |
|
|
UHT
1850
Universal Health Realty Income Trust
UHT
$603M
| $1.93M | ﹤0.01% |
29,420
+304
| +1% | +$18.3K |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.